A Brent Carter Selected Research

NADPH Oxidase 4

1/2021	NOX4 regulates macrophage apoptosis resistance to induce fibrotic progression.
1/2019	NOX4 modulates macrophage phenotype and mitochondrial biogenesis in asbestosis.
1/2017	NADPH Oxidase 4 (Nox4) Suppresses Mitochondrial Biogenesis and Bioenergetics in Lung Fibroblasts via a Nuclear Factor Erythroid-derived 2-like 2 (Nrf2)-dependent Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Brent Carter Research Topics

Disease

19	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 07/2008
18	Fibrosis (Cirrhosis) 12/2023 - 07/2008
5	Inflammation (Inflammations) 04/2021 - 01/2002
5	Asbestosis 01/2021 - 07/2008
4	Lung Injury 01/2023 - 08/2015
4	Infections 01/2023 - 01/2002
3	Idiopathic Pulmonary Fibrosis 12/2023 - 11/2019
3	Lung Diseases (Lung Disease) 01/2023 - 06/2002
2	Pancreatitis 08/2010 - 01/2008
2	Respiratory Syncytial Virus Infections 12/2003 - 01/2002
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Pneumonia (Pneumonitis) 11/2018
1	Pathologic Processes 01/2017
1	Choristoma (Ectopic Tissue) 01/2016
1	Neoplasms (Cancer) 12/2015
1	Emphysema 08/2015
1	Asthma (Bronchial Asthma) 01/2015
1	Airway Remodeling 01/2015
1	Werner Syndrome (Werner's Syndrome) 09/2014
1	Vascular System Injuries 05/2012
1	Neointima 05/2012
1	Silicosis 07/2008
1	Pneumoconiosis 07/2008
1	Gallstones (Gallstone) 01/2008
1	Acute Lung Injury 06/2005

Drug/Important Bio-Agent (IBA)

12	AsbestosIBA 01/2023 - 06/2002
10	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 11/2007
6	Proteins (Proteins, Gene)FDA Link 11/2019 - 12/2003
5	CytokinesIBA 12/2015 - 01/2002
4	Bleomycin (Blenoxane)FDA LinkGeneric 10/2023 - 01/2016
4	CadmiumIBA 01/2023 - 08/2015
4	CollagenIBA 01/2020 - 04/2011
3	SmokeIBA 01/2021 - 08/2015
3	NADPH Oxidase 4IBA 01/2021 - 01/2017
3	Phosphotransferases (Kinase)IBA 03/2016 - 01/2008
3	Superoxide Dismutase-1IBA 01/2016 - 04/2011
2	Particulate MatterIBA 12/2023 - 01/2021
2	mitochondrial calcium uniporterIBA 01/2022 - 01/2019
2	EnzymesIBA 01/2017 - 04/2011
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2016 - 05/2012
2	Serpentine Asbestos (Chrysotile)IBA 08/2015 - 11/2014
2	AntioxidantsIBA 01/2015 - 04/2011
2	NF-kappa B (NF-kB)IBA 08/2010 - 01/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008 - 12/2003
1	indium-bleomycinIBA 12/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	NADP (NADPH)IBA 01/2023
1	Heavy MetalsIBA 01/2023
1	HydrogenIBA 01/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023
1	ulixertinibIBA 01/2023
1	venetoclaxIBA 01/2022
1	Gold CompoundsIBA 04/2021
1	VimentinIBA 01/2021
1	SootIBA 01/2021
1	serum P-component (CIt)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	ChemokinesIBA 01/2020
1	Plasminogen Activator Inhibitor 1IBA 10/2017
1	Tyrosine (L-Tyrosine)FDA Link 01/2016
1	Leflunomide (Arava)FDA LinkGeneric 01/2016
1	digeranyl bisphosphonateIBA 09/2015
1	Terpenes (Terpenoids)IBA 09/2015
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 09/2015
1	SolutionsIBA 08/2015
1	Cadmium Chloride (Cadmium Dichloride)IBA 08/2015
1	Scavenger Receptors (Scavenger Receptor)IBA 08/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2015
1	Heme (Haem)IBA 08/2015
1	AllergensIBA 01/2015
1	Interleukin-13IBA 01/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2015
1	Mevalonic Acid (Mevalonate)IBA 12/2014
1	Caspase 9IBA 12/2014
1	Acrolein (Aqualin)IBA 09/2014
1	RecQ HelicasesIBA 09/2014
1	Cytochromes c (Cytochrome c)IBA 01/2012
1	Cysteine (L-Cysteine)FDA Link 01/2012
1	GTP Phosphohydrolases (GTPases)IBA 01/2012
1	rac1 GTP-Binding ProteinIBA 08/2010
1	LuciferasesIBA 08/2010
1	MitogensIBA 08/2010
1	CatalaseIBA 11/2009
1	InflammasomesIBA 07/2008
1	Silicon Dioxide (Silica)FDA LinkGeneric 07/2008
1	LipidsIBA 06/2005
1	Surface-Active Agents (Surfactants)IBA 06/2005
1	OxysterolsIBA 06/2005
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2003
1	Messenger RNA (mRNA)IBA 12/2003
1	Oxidants (Oxidizing Agents)IBA 06/2002
1	DNA (Deoxyribonucleic Acid)IBA 01/2002
1	Glycogen Synthase Kinase 3IBA 01/2002
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2002
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2002

Therapy/Procedure

2	Ligation 05/2012 - 01/2008
1	Therapeutics 01/2015